Latest Indonesia News

Stellar Resources has boosted its Heemskirk Tin Project resource by 64% at Severn, pushing total contained tin to over 129,000 tonnes, while advancing prefeasibility studies and securing a $22.1 million capital raise.

Ardea Resources is pushing forward its Kalgoorlie Nickel Project’s Goongarrie Hub with a fully funded $98.5 million Definitive Feasibility Study, underpinned by multi-jurisdictional government support and strategic partnerships with Japanese industry giants.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

Yancoal's June quarter saw a 20% jump in attributable saleable coal production to 10.8 million tonnes, supported by rising realised coal prices and operational improvements. The company advances its strategic growth with the pending acquisition of an 80% stake in the Kestrel Coal Mine, while planning to close Ashton mine by early 2028.

PT ANTAM has raised its 2025 cash dividend by 38%, distributing Rp5.05 trillion to shareholders, reflecting strong profitability and a sustained commitment to shareholder returns.

Bass Oil reported a 3% production increase in June 2026, driven by Indonesian output and Cooper Basin gains. The Bunian 6 well drilling is underway, expected to double group production, while the Vanessa gas field acquisition opens new gas sales and commercialisation pathways.

Loyal Metals has sent its Scheme Booklet to shareholders detailing the proposed A$0.45 per share acquisition by PT Bumi Resources, setting the stage for a shareholder vote on 20 August 2026.

BPH Global has kicked off direct seaweed exports to China, reporting AUD 535,895 in sales for the latest trading period and expanding its footprint beyond Indonesia.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.

ReNerve Limited has secured regulatory approval to market its flagship NervAlign Nerve Cuff in Indonesia, marking a major step in its Asia-Pacific expansion and unlocking access to one of the region’s largest nerve repair markets.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.